Nature Reviews Cancer 11, 541–557 (2011)

In Table 2 of this article, there were errors in two of the cells. In the Sunitinib row, under the 'Tumour types' heading, "GIST" should have read "Imatinib-resistant GIST". Also in the Sunitinib row, under the 'Approximate response rate' heading, "80%" should have read "8%". This has now been corrected online.